- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Enlarged Prostate in Canada
Total 742 results
-
University of British ColumbiaUniversity Health Network, Toronto; Janssen Inc.RecruitingGenomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer (GUNS)Prostate CancerCanada, United States
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada, Czech Republic, Germany, Hungary, Mexico, Netherlands, Puerto Rico, Romania, Russian Federation, Ukraine, United Kingdom
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate Cancer | Prostate Cancer MetastaticFrance, Switzerland, Spain, Italy
-
Sunnybrook Health Sciences CentreOntario Institute for Cancer ResearchCompleted
-
Canadian Cancer Trials GroupCanadian Cancer Clinical Trials Network; BC Cancer FoundationActive, not recruiting
-
ExelixisTakeda; Roche-GenentechActive, not recruitingMetastatic Prostate Cancer | Prostate AdenocarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Russian Federation, Singapore, Spain, ... and more
-
ExelixisTerminatedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States, Canada, Australia, United Kingdom, Ireland
-
BayerOrion Corporation, Orion PharmaCompletedProstate Cancer Non-Metastatic | Castration-ResistantBelgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Czech Republic, Hungary, Romania, Canada
-
LTN PHARMACEUTICALS, INC.TerminatedProstate CancerUnited States, Canada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI)Completed
-
NCIC Clinical Trials GroupS*BIOCompleted
-
AbbVieJSS Medical Research; CMX Research Inc.; Canadian Urology Research ConsortiumCompleted
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
Astex Pharmaceuticals, Inc.CompletedProstate CancerUnited States, United Kingdom, Spain, Canada
-
CMX ResearchSanofiCompleted
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
Centre hospitalier de l'Université de Montréal...McMaster University; Queen's University; London Health Sciences Centre; Canadian... and other collaboratorsActive, not recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
IpsenCompleted
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompleted
-
NCIC Clinical Trials GroupCompletedProstate CancerUnited States, Canada
-
Ontario Clinical Oncology Group (OCOG)Canadian Institutes of Health Research (CIHR); Trans Tasman Radiation Oncology...Completed
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States, Canada
-
University Health Network, TorontoActive, not recruiting
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
POINT Biopharma, a wholly owned subsidiary of Eli...Active, not recruitingMetastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, Sweden, France, United Kingdom
-
ExelixisCompletedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerBelgium, France, Italy, Canada, United States, Germany, United Kingdom, Australia, Netherlands, Spain, Austria, Ireland, Puerto Rico, Sweden
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Southwest Oncology GroupCompleted
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
NCIC Clinical Trials GroupOncothyreon Canada Inc.Completed
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate CancerHong Kong, Canada, China, Germany, Spain, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Australia, Denmark, France, United States, Singapore, Poland, Malaysia, Turkey, Belgium, Argentina, Thailand, Slovakia, Brazil, Finland, Ita... and more
-
ESSA PharmaceuticalsRecruitingProstate CancerUnited States, Canada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Institute... and other collaboratorsTerminated
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerCanada, United States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstate Cancer MetastaticCanada, Germany, United States, Israel, Puerto Rico, Taiwan, Korea, Republic of, Australia, Chile, China, France, Norway, Czechia, Finland, Hong Kong, Netherlands, Poland, Spain, Sweden, Turkey, Denmark, Hungary, Italy, United Kingdom
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Netherlands, Hungary, Czech Republic, Germany, Mexico, Romania, Russian Federation, Ukraine, Canada, Puerto Rico, United Kingdom
-
MedImmune LLCCompletedProstate CancerUnited States, Belgium, Israel, Russian Federation, Canada, Hungary, Poland
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Hormone Sensitive Prostate CancerCanada, United States, France, Spain, Australia, Sweden, Taiwan, Finland, Korea, Republic of, Netherlands, United Kingdom, Denmark, Brazil, Slovakia, Austria, Italy, Poland
-
BayerActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Austria, Czechia, Israel, Italy, Germany, United Kingdom, France, Mexico, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Denmark, Sweden, Argentina, Portugal
-
Eisai Inc.CompletedProstate CancerFrance, United States, Romania, Canada, Peru, Brazil, Russian Federation, Chile, Croatia
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
GlaxoSmithKlineCompletedNeoplasms, ProstateUnited States, Canada
-
Active Biotech ABCompleted